Haleon had a net margin of 10.85% and a return on equity of 14.76%. The company had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion.
Hsbc Global Res lowered shares of Haleon (NYSE:HLN – Free Report) from a strong-buy rating to a hold rating in a research note issued to investors on Wednesday morning,Zacks.com reports.
In a key development for Pakistan’s pharmaceutical sector, Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, has successfully exported Centrum—a ...
From left: Satheeskanth Sithambaram (Snr. Manager – Medical Marketing, Haleon Lanka), Harsha Ratnayake (Marketing Lead – Haleon Lanka), Manjula Weerakoon (Commercial Lead – Sri Lanka ...
Haleon Sri Lanka formerly known as GlaxoSmithKline Healthcare; the first multinational pharmaceutical manufacturing organization in Sri Lanka, which commenced manufacturing in 1956 with the flagship ...
Shares of Haleon PLC HLN rallied 4.18% to £3.98 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.61% to 8,809.74.
MANILA, Philippines — The Commission on Elections (Comelec) expects the canvassing of votes for senators and party-list groups in the May 12 elections to be completed in a week at most.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
British consumer healthcare group Haleon disappointed investors on Thursday after the Sensodyne toothpaste maker said 2025 revenue growth would be weighted to the second half of the year ...
In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading ...
In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other stocks Jim Cramer discussed. In a recent appearance on CNBC’s Squawk on the Street ...
Pfizer sells entire Haleon stake for $3.24 billion Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results